| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 762473 | 1181286010 | HYRIMOZ 80 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | HYRIMOZ 80 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 0,8 ml | 80 mg inyectable 0,8 ml | 113 | 1 | 49 | 1 pluma precargada de 0,8 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181286010/1181286010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181286010/1181286010_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5172 | SANDOZ FARMACEUTICA S.A. | 2023-04-25 | 1 | 1 | 1 | 2023-04-26 | 2023-04-25 | 1 | 2023-12-15 | View Edit Delete | ||||||||||||
| 762540 | 1181286012 | HYRIMOZ 40 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | HYRIMOZ 40 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 2 jeringas precargadas de 0,4 ml | 40 mg inyectable 0,4 ml | 33 | 2 | 61 | 2 jeringas precargadas de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181286012/1181286012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181286012/1181286012_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5172 | SANDOZ FARMACEUTICA S.A. | 2023-04-25 | 1 | 1 | 1 | 2023-04-26 | 2023-04-25 | 1 | 2023-11-28 | View Edit Delete | ||||||||||||
| 762475 | 1181286015 | HYRIMOZ 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | HYRIMOZ 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 0,4 ml | 40 mg inyectable 0,4 ml | 66 | 1 | 49 | 1 pluma precargada de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181286015/1181286015_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181286015/1181286015_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5172 | SANDOZ FARMACEUTICA S.A. | 2023-04-25 | 1 | 1 | 1 | 2023-04-26 | 2023-04-25 | 1 | 2023-11-22 | View Edit Delete | ||||||||||||
| 762476 | 1181286015 | HYRIMOZ 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | HYRIMOZ 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 2 plumas precargadas de 0,4 ml | 40 mg inyectable 0,4 ml | 66 | 2 | 49 | 2 plumas precargadas de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181286015/1181286015_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181286015/1181286015_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5172 | SANDOZ FARMACEUTICA S.A. | 2023-04-25 | 1 | 1 | 1 | 2023-04-26 | 2023-04-25 | 1 | 2023-11-22 | View Edit Delete | ||||||||||||
| 722193 | 1181289001 | BIKTARVY 50 MG/200 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | BIKTARVY 50 MG/200 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 50 mg/200 mg/ 25 mg | 6 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181289001/1181289001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181289001/1181289001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16632 | GILEAD SCIENCES S.L. | 2018-07-10 | 1 | 1 | 1 | 2018-07-11 | 2018-07-10 | 1 | 2019-02-15 | View Edit Delete | ||||||||||||
| 726062 | 1181291002 | RIZMOIC 200 MICROGRAMOS COMPRIMIDOS RECUBIERTOS CON PELICULA | RIZMOIC 200 MICROGRAMOS COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 200 microgramos | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181291002/1181291002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181291002/1181291002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42433 | CASEN RECORDATI S.L. | 2019-06-28 | 1 | 1 | 1 | 2019-06-29 | 2019-06-28 | 1 | 2021-04-14 | View Edit Delete | ||||||||||||
| 723375 | 1181293001 | AIMOVIG 70 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | AIMOVIG 70 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 1 ml | 70 mg inyectable 1 ml | 66 | 1 | 49 | 1 pluma precargada de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181293001/1181293001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181293001/1181293001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2018-08-28 | 1 | 1 | 1 | 2018-08-29 | 2018-08-28 | 1 | 2019-10-14 | View Edit Delete | ||||||||||||
| 725624 | 1181293004 | AIMOVIG 140 MG SOLUCIÓN INYECTABLE EN PLUMA PRECARGADA | AIMOVIG 140 MG SOLUCIÓN INYECTABLE EN PLUMA PRECARGADA, 1 pluma precargada de 1 ml | 140 mg inyectable 1 ml | 66 | 1 | 49 | 1 pluma precargada de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181293004/1181293004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181293004/1181293004_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2019-06-13 | 1 | 1 | 1 | 2019-06-14 | 2019-06-13 | 1 | 2019-10-14 | View Edit Delete | ||||||||||||
| 767412 | 1181294002 | RXULTI 0,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | RXULTI 0,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 0,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181294002/1181294002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181294002/1181294002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29813 | OTSUKA PHARMACEUTICAL S.A. | 2025-04-09 | 1 | 1 | 1 | 2025-04-10 | 2025-04-09 | 1 | 2025-09-02 | View Edit Delete | ||||||||||||
| 724707 | 1181294003 | RXULTI 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | RXULTI 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 10 comprimidos | 1 mg | 5 | 10 | 10 | 10 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181294003/1181294003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181294003/1181294003_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29813 | OTSUKA PHARMACEUTICAL S.A. | 2019-03-25 | 1 | 1 | 1 | 2019-03-26 | 2019-03-25 | 1 | 2024-03-13 | View Edit Delete | ||||||||||||
| 730293 | 1181294003 | RXULTI 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | RXULTI 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 1 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181294003/1181294003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181294003/1181294003_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29813 | OTSUKA PHARMACEUTICAL S.A. | 2019-03-25 | 1 | 1 | 1 | 2019-03-26 | 2021-02-01 | 1 | 2024-05-14 | View Edit Delete | ||||||||||||
| 724739 | 1181294005 | RXULTI 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | RXULTI 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 2 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181294005/1181294005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181294005/1181294005_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29813 | OTSUKA PHARMACEUTICAL S.A. | 2019-03-25 | 1 | 1 | 1 | 2019-03-26 | 2019-03-25 | 1 | 2024-03-13 | View Edit Delete | ||||||||||||
| 724741 | 1181294006 | RXULTI 3 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, | RXULTI 3 MG COMPRIMIDOS RECUBIERTOS CON PELICULA,, 28 comprimidos | 3 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181294006/1181294006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181294006/1181294006_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29813 | OTSUKA PHARMACEUTICAL S.A. | 2019-03-25 | 1 | 1 | 1 | 2019-03-26 | 2019-03-25 | 1 | 2024-03-13 | View Edit Delete | ||||||||||||
| 724742 | 1181294007 | RXULTI 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | RXULTI 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 4 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181294007/1181294007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181294007/1181294007_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29813 | OTSUKA PHARMACEUTICAL S.A. | 2019-03-25 | 1 | 1 | 1 | 2019-03-26 | 2019-03-25 | 1 | 2024-03-13 | View Edit Delete | ||||||||||||
| 723755 | 1181295001 | TRAZIMERA 150 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | TRAZIMERA 150 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 15 ml | 150 mg | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181295001/1181295001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181295001/1181295001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | PFIZER S.L. | 2018-11-30 | 1 | 1 | 1 | 2018-12-01 | 2018-11-30 | 1 | 2019-03-14 | View Edit Delete | ||||||||||||
| 726605 | 1181295002 | TRAZIMERA 420 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | TRAZIMERA 420 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 420 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181295002/1181295002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181295002/1181295002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | PFIZER S.L. | 2019-10-23 | 1 | 1 | 1 | 2019-10-24 | 2019-10-23 | 1 | 2020-01-13 | View Edit Delete | ||||||||||||
| 726627 | 1181296002 | TEGSEDI 284 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | TEGSEDI 284 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 4 jeringas precargadas de 1,5 ml | 284 mg inyectable 1,5 ml | 33 | 4 | 61 | 4 jeringas precargadas de 1,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181296002/1181296002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181296002/1181296002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 70091 | SWEDISH ORPHAN BIOVITRUM S.L. | 2019-09-09 | 1 | 1 | 1 | 2019-09-10 | 2019-09-09 | 1 | 2020-04-14 | View Edit Delete | ||||||||||||
| 723579 | 1181297001 | KYMRIAH 1,2 x 10e6 - 6,0 x 10e8 celulas dispersion para perfusion | KYMRIAH 1,2 x 10e6 - 6,0 x 10e8 celulas dispersion para perfusion 1-3 bolsas de perfusión (1 dosis de tratamiento individual) | 1,2 x 10e6 - 6,0 x 10e8 celulas dispersion para perfusion | 3 | 1-3 | 65 | 1-3 bolsas de perfusión (1 dosis de tratamiento individual) | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1181297001/1181297001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181297001/1181297001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2018-09-17 | 1 | 1 | 1 | 2018-09-18 | 2018-09-17 | 1 | 2018-12-12 | View Edit Delete | ||||||||||||
| 723562 | 1181299001 | YESCARTA 0,4 - 2 x 10e8 CELULAS DISPERSION PARA PERFUSION | YESCARTA 0,4 - 2 x 10e8 CELULAS DISPERSION PARA PERFUSION 1 bolsa de 68 ml | 0,4 - 2 x 10e8 células | 3 | 1 | 65 | 1 bolsa de 68 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1181299001/1181299001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181299001/1181299001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 35342 | GILEAD SCIENCES S.L. | 2018-09-06 | 1 | 1 | 1 | 2018-09-07 | 2018-09-06 | 1 | 2019-06-12 | View Edit Delete | ||||||||||||
| 723571 | 1181301001 | MEPSEVII 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | Mepsevii 2 mg/ml concentrado para solucion para perfusion, 1 vial de 5 ml | 2 mg/ml inyectable perfusión 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1181301001/1181301001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181301001/1181301001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 35117 | ULTRAGENYX GERMANY GMBH | 2018-09-19 | 1 | 1 | 1 | 2018-09-20 | 2018-09-19 | 1 | 2021-06-11 | View Edit Delete |
Page 102 of 1035, showing 20 records out of 20689 total, starting on record 2021, ending on 2040